B Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates
International Journal of Molecular Sciences · 04.07.2024 · 25 (13) · 7351
DOI: 10.3390/ijms25137351 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2024. Verfasst von Soňa Tkáčiková und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Clinical Biophysics, Faculty of Medicine, University of Pavol Jozef Šafárik in Košice, Trieda SNP 1, 04011 Košice, Slovakia. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, B-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovak Research and Development Agency.
Abstract (Originalsprache)
Despite advances in the genomic classification of breast cancer, current clinical tests and treatment decisions are commonly based on protein-level information. Nowadays breast cancer clinical treatment selection is based on the immunohistochemical (IHC) determination of four protein biomarkers: Estrogen Receptor 1 (ESR1), Progesterone Receptor (PGR), Human Epidermal Growth Factor Receptor 2 (HER2), and proliferation marker Ki-67. The prognostic correlation of tumor-infiltrating T cells has been widely studied in breast cancer, but tumor-infiltrating B cells have not received so much attention. We aimed to find a correlation between immunohistochemical results and a proteomic approach in measuring the expression of proteins isolated from B-cell lymphocytes in peripheral blood samples. Shotgun proteomic analysis was chosen for its key advantage over other proteomic methods, which is its comprehensive and untargeted approach to analyzing proteins. This approach facilitates better characterization of disease-associated changes at the protein level. We identified 18 proteins in B cell lymphocytes with a significant fold change of more than 2, which have promising potential to serve as breast cancer biomarkers in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Clinical Biophysics, Faculty of Medicine, University of Pavol Jozef Šafárik in Košice, Trieda SNP 1, 04011 Košice, Slovakia.
- Center of Clinical and Preclinical Research MEDIPARK, Faculty of Medicine, University of Pavol Jozef Šafárik in Košice, Trieda SNP 1, 04011 Košice, Slovakia.
- Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Pavol Jozef Šafárik and UNLP in Košice, Trieda SNP 1, 04011 Košice, Slovakia.
- 1st Department of Surgery, Faculty of Medicine, University of Pavol Jozef Šafárik and UNLP in Košice, Trieda SNP 1, 04011 Košice, Slovakia.
ORCID-Profile: Soňa Tkáčiková, Miroslav Marcin, Peter Bober, Peter Urdzík, Ján Fedačko
Förderung
- Slovak Research and Development Agency
Zitieren
APA
Tkáčiková, S., Marcin, M., Bober, P., Kacírová, M., Šuliková, M., Parnica, J., Tóth, D., Lenárt, M., Radoňak, J., Urdzík, P., Fedačko, J., & Sabo, J. (2024). B Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates. International Journal of Molecular Sciences, 25(13), 7351. https://doi.org/10.3390/ijms25137351
Vancouver
Tkáčiková S, Marcin M, Bober P, Kacírová M, Šuliková M, Parnica J, et al. B Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates. International Journal of Molecular Sciences. 2024;25(13):7351. doi:10.3390/ijms25137351
BibTeX
@article{Tkikov2024,
author = {Tkáčiková, Soňa and Marcin, Miroslav and Bober, Peter and Kacírová, Mária and Šuliková, Michaela and Parnica, Jozef and Tóth, Dávid and Lenárt, Marek and Radoňak, Jozef and Urdzík, Peter and Fedačko, Ján and Sabo, Ján},
title = {B Cell Lymphocytes as a Potential Source of Breast Carcinoma Marker Candidates},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7351},
doi = {10.3390/ijms25137351}
}
EUVIMED